{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:23:19Z","timestamp":1757618599668,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40272-025-00709-2","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:39:32Z","timestamp":1751891972000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use"],"prefix":"10.1007","volume":"27","author":[{"given":"Armelle","family":"Hornard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Severac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Laugel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Abi Ward\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bansept","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"de Feraudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Aude","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Eyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"de Saint Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-2552","authenticated-orcid":false,"given":"Sarah","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"709_CR1","doi-asserted-by":"publisher","unstructured":"Chin RFM, Neville BGR, Peckham C, Bedford H, Wade A, Scott RC. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(06)69043-0","DOI":"10.1016\/S0140-6736(06)69043-0"},{"key":"709_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.seizure.2023.05.020","volume":"109","author":"C Schnier","year":"2023","unstructured":"Schnier C, Chin RF. Mortality in children with epilepsy: cohort study using the Clinical Practice Research Datalink. Seizure. 2023;109:77\u201382.","journal-title":"Seizure"},{"issue":"10","key":"709_CR3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus: report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"},{"issue":"2","key":"709_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/epi4.12707","volume":"8","author":"S Meyer","year":"2023","unstructured":"Meyer S, Langer J, Poryo M, Bay JG, Wagenpfeil S, Heinrich B, et al. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: a multicenter, national, two-year prospective surveillance study. Epilepsia Open. 2023;8(2):411\u201324.","journal-title":"Epilepsia Open"},{"key":"709_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.seizure.2023.07.022","volume":"111","author":"M Jindal","year":"2023","unstructured":"Jindal M, Neligan A, Rajakulendran S. Early and established status epilepticus: the impact of timing of intervention, treatment escalation and dosing on outcome. Seizure. 2023;111:98\u2013102.","journal-title":"Seizure"},{"issue":"1","key":"709_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr"},{"key":"709_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jns.2016.10.004","volume":"370","author":"JY Cheng","year":"2016","unstructured":"Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290\u20135.","journal-title":"J Neurol Sci"},{"issue":"10231","key":"709_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217\u201324.","journal-title":"Lancet"},{"issue":"10186","key":"709_CR9","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","volume":"393","author":"MD Lyttle","year":"2019","unstructured":"Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125\u201334.","journal-title":"Lancet"},{"issue":"10186","key":"709_CR10","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","volume":"393","author":"SR Dalziel","year":"2019","unstructured":"Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135\u201345.","journal-title":"Lancet"},{"issue":"3","key":"709_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"28","key":"709_CR12","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"key":"709_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.110105","volume":"161","author":"A Strzelczyk","year":"2024","unstructured":"Strzelczyk A, Brunklaus A, Rosenow F, Paprocka J, Schubert-Bast S, K\u00e4mppi L. Cost-of-illness review of status epilepticus in Europe. Epilepsy Behav. 2024;161: 110105.","journal-title":"Epilepsy Behav"},{"issue":"9","key":"709_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/dmcn.14900","volume":"63","author":"C Mitchell","year":"2021","unstructured":"Mitchell C, Chatterton Dickson L, Ramsay A, Mesalles-Naranjo O, Leonard P, Brand C, et al. Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study. Dev Med Child Neuro. 2021;63(9):1075\u201384.","journal-title":"Dev Med Child Neuro"},{"issue":"9","key":"709_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1528-1167.2007.01175.x","volume":"48","author":"M Raspall-Chaure","year":"2007","unstructured":"Raspall-Chaure M, Chin RFM, Neville BG, Bedford H, Scott RC. The epidemiology of convulsive status epilepticus in children: a critical review: epidemiology of status epilepticus. Epilepsia. 2007;48(9):1652\u201363.","journal-title":"Epilepsia"},{"issue":"3","key":"709_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13312-020-1755-4","volume":"57","author":"V Vignesh","year":"2020","unstructured":"Vignesh V, Rameshkumar R, Mahadevan S. Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial. Indian Pediatr. 2020;57(3):222\u20137.","journal-title":"Indian Pediatr"},{"issue":"9","key":"709_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1177\/0883073816641187","volume":"31","author":"R \u0130\u015fg\u00fcder","year":"2016","unstructured":"\u0130\u015fg\u00fcder R, G\u00fczel O, Ceylan G, Y\u0131lmaz \u00dc, A\u011f\u0131n H. A Comparison of intravenous levetiracetam and valproate for the treatment of refractory status epilepticus in children. J Child Neurol. 2016;31(9):1120\u20136.","journal-title":"J Child Neurol"},{"issue":"4","key":"709_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3988\/jcn.2019.15.4.468","volume":"15","author":"N Noureen","year":"2019","unstructured":"Noureen N, Khan S, Khursheed A, Iqbal I, Maryam M, Sharib SM, et al. Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: an open-label randomized controlled trial. J Clin Neurol. 2019;15(4):468.","journal-title":"J Clin Neurol"},{"issue":"2","key":"709_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14581\/jer.20011","volume":"10","author":"M Nazir","year":"2020","unstructured":"Nazir M, Tarray RA, Asimi R, Syed WA. Comparative efficacy of IV phenytoin, IV valproate, and IV levetiracetam in childhood status epilepticus. J Epilepsy Res. 2020;10(2):69\u201373.","journal-title":"J Epilepsy Res"},{"key":"709_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107289","volume":"111","author":"GE Besli","year":"2020","unstructured":"Besli GE, Yuksel Karatoprak E, Yilmaz S. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Epilepsy Behav. 2020;111: 107289.","journal-title":"Epilepsy Behav"},{"issue":"7","key":"709_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00381-022-05543-2","volume":"38","author":"MT K\u00f6le","year":"2022","unstructured":"K\u00f6le MT, Sager SG, Zeynel H, \u00c7a\u011f Y, Ak\u0131n Y. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Childs Nerv Syst. 2022;38(7):1357\u201364.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"709_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/jpn.JPN_109_19","volume":"15","author":"A Handral","year":"2020","unstructured":"Handral A, Veerappa BG, Gowda VK, Shivappa SK, Benakappa N, Benakappa A. Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: a randomized controlled trial. J Pediatr Neurosci. 2020;15(3):252\u20136.","journal-title":"J Pediatr Neurosci"},{"issue":"10","key":"709_CR23","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.4103\/jfmpc.jfmpc_750_19","volume":"8","author":"G Wani","year":"2019","unstructured":"Wani G, Imran A, Dhawan N, Gupta A, Giri J. Levetiracetam versus phenytoin in children with status epilepticus. J Family Med Prim Care. 2019;8(10):3367.","journal-title":"J Family Med Prim Care"},{"issue":"7","key":"709_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12098-020-03221-2","volume":"87","author":"S Nalisetty","year":"2020","unstructured":"Nalisetty S, Kandasamy S, Sridharan B, Vijayakumar V, Sangaralingam T, Krishnamoorthi N. Clinical effectiveness of levetiracetam compared to fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus. Indian J Pediatr. 2020;87(7):512\u20139.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"709_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/JPN.JPN_126_17","volume":"13","author":"K Singh","year":"2018","unstructured":"Singh K, Aggarwal A, Faridi M, Sharma S. IV Levetiracetam versus IV phenytoin in childhood seizures: a randomized controlled trial. J Pediatr Neurosci. 2018;13(2):158.","journal-title":"J Pediatr Neurosci"},{"issue":"5","key":"709_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/1742-6723.13988","volume":"34","author":"JS Furyk","year":"2022","unstructured":"Furyk JS, George S, Phillips N, Emeto TI, Watt K, O\u2019Brien S, et al. Status Epilepticus Australasian Registry for Children: a pilot prospective, observational, cohort study of paediatric status epilepticus. Emerg Med Australas. 2022;34(5):801\u20137.","journal-title":"Emerg Med Australas"},{"key":"709_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.809536","volume":"9","author":"E Sanford Kobayashi","year":"2022","unstructured":"Sanford Kobayashi E, Waldman B, Engorn BM, Perofsky K, Allred E, Briggs B, et al. Cost efficacy of rapid whole genome sequencing in the pediatric intensive care unit. Front Pediatr. 2022;9: 809536.","journal-title":"Front Pediatr"},{"issue":"5","key":"709_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/WNF.0000000000000229","volume":"40","author":"A Kartal","year":"2017","unstructured":"Kartal A. Can High-dose levetiracetam be safe? A case report of prolonged accidental high-dose levetiracetam administration and review of the literature. Clin Neuropharmacol. 2017;40(5):217.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"709_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eplepsyres.2010.06.009","volume":"91","author":"M Obeid","year":"2010","unstructured":"Obeid M, Pong AW. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy. Epilepsy Res. 2010;91(1):101\u20135.","journal-title":"Epilepsy Res"},{"issue":"6","key":"709_CR30","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.17241","volume":"63","author":"N Specchio","year":"2022","unstructured":"Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1398\u2013442.","journal-title":"Epilepsia"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-025-00709-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:19:37Z","timestamp":1757207977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-025-00709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1007\/s40272-025-00709-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"type":"print","value":"1174-5878"},{"type":"electronic","value":"1179-2019"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"23 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Armelle Hornard, Fran\u00e7ois Severac, Vincent Laugel, Marie-Th\u00e9r\u00e8se Abi Warde, Claire Bansept, Yvan de Feraudy, Sandrine Haupt, Marie-Aude Spitz, Didier Eyer, Anne de Saint Martin, and Sarah Baer have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"We have read the Journal\u2019s position on ethical publication issues and confirm that this report complies with these guidelines. The study received approval from the Ethics Committee of the University Hospital of Strasbourg with the following number: CE-2023-120.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed and signed consent was obtained from the patient\u2019s caregiver or guardian to analyze all participants in compliance with the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Detailed clinical data and materials can be requested from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"AH, SB, AdSM, and VL contributed to the study design and conceptualization, data collection, analysis, interpretation of data, and drafting of the original manuscript. M-TAW, CB, YdF, SH, M-AS, and DE contributed to the data collection and interpretation, and to revising the manuscript for intellectual content. FS performed the statistical analysis.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}